Treatment of HIV-associated facial lipoatrophy: Impact on infection progression assessed by viral load and CD4 count;Suptratamento da lipoatrofia facial associada ao HIV/aids: O impacto sobre a progressão da infecção avaliada pela contagem de CD4 e carga viral

Anais Brasileiros de Dermatologia

Volumn 88, Issue 4, 2013, Pages 570-577

  Soares, Flávia Machado Gonçalves ^a   Costa, Izelda Maria Carvalho ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CD4 positive T lymphocytes; HIV; HIV associated lipodystrophy syndrome; Polymethyl methacry late; Viral load

Indexed keywords

PARACETAMOL; POLY (METHYL METHACRYLATE); UNCLASSIFIED DRUG;

ADULT; AIN; ARTICLE; ASEPSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DERMAL IMPLANT; DISEASE ASSOCIATION; DISEASE COURSE; FACIAL LIPOATROPHY; FEMALE; HEMOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOATROPHY; MALE; PAIN; PROSPECTIVE STUDY; VIRUS LOAD;

ADULT; BIOCOMPATIBLE MATERIALS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FACE; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84884757874     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.2013895     Document Type: Article

References (28)

1. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulinresistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F58.
2. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read. 2000;10:546-550.
3. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, AIDS e Hepatites Virais. Manual de tratamento da lipoatrofia facial: recomendações para o preenchimento facial com polimetilmetacrilato em portadores de HIV/AIDS. Brasília: Ministério da Saúde; 2009. 44 p. (Série A. Normas e Manuais Técnicos).
4. Behrens GMN, Stoll M, Schimidt RE. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf. 2000;23:57-76.
5. Cabrero E, Griffa L, Burgos A; HIV Body Physical Changes Study Group. Prevalence and impact of body physical changes in HIV patients treated with highly active antire-troviral therapy: results from a study on patient and physician perceptions. AIDS Patient Care STDS. 2010;24:5-13.
6. Chen D, Misra A, Garg A. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab. 2002;87:4845-4856.
7. Baril JG, Junod P, Leblanc R, Dion H, Therrien R, Laplante F, et al. HIV-associated lipo-dystrophy syndrome: A review of clinical aspects. Can J Infect Dis Med Microbiol. 2005;16:233-243.
8. Li HY, Silva ACCM, Santos S. Síndrome Lipodistrófica e HIV/AIDS. J Bras Aids. 2002;3:23-35.
9. Kavouni A, Catalan J, Brown S, Mandalia S, Barton SE. The face of HIV and AIDS: can we erase the stigma? AIDS Care. 2008;20:485-487.
10. Milinkovic A, Martinez E. Current perspectives on HIV-associated lipodystrophy syndrome. J Antimicrob Chemother. 2005;56:6-9.
11. Pujol RM, Domingo P, Xavier-Matias-Guiu, Francia E, Sanbeat MA, Alomar A, et al. HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases. J Am Acad Dermatol. 2000;42:193-198.
12. Baril JG, Junod P, Leblanc R, Dion H, Therrien R, Laplante F, et al. HIV-associated lipo-dystrophy syndrome: A review of clinical aspects. Infect Dis Med Microbiol. 2005;16:233-243.
13. Narins RS. Minimizing Adverse Events Associated with Poly-L-latic Acid Injection. Dermatol Surg. 2008;34:S100-S104.
14. Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy. AIDS Patient Care STDS. 2009;23:699-714.
15. Skeie L, Bugge H, Negaard A, Bergersen BM. Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study. HIV Med. 2010;11:170-177.
16. Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7:181-185.
17. Chandra PS, Gandhi C, Satishchandra P, Kamat A, Desai A, Ravi V, et al. Quality of life in HIV subtype C infection among asymptomatic subjects and its association with CD4 counts and viral loads--a study from South India. Qual Life Res. 2006;15:1597-1605.
18. Lomar AV, Diament D. Terapia Anti-retroviral. In: Veronesi R, Focaccia R, editores. Tratado de infectologia. São Paulo: Atheneu; 2005. p. 235-241.
19. Rizzo LV. Imunopatogênese. In: Veronesi R, Focaccia R, editores. Tratado de infecto-logia. São Paulo: Atheneu; 2005. p.138-142.
20. Ironson G, Ócleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67:1013-1021.
21. Kiecolt-Glaser J, McGuire L, Robies TF, Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol. 2002;70:537-547.
22. Antoni MH, Cruess DG, Klimas N, Maher K, Cruess S, Kumar M, et al. Stress Management andImmune System Reconstitution in Symptomatic HIV-Infected Gay Men Over Time: Effects on Transitional Naïve T Cells (CD4+CD45RA+CD29+). Am J Psychiatry. 2002:159:143-144.
23. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med.2004;66:272-275.
24. Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med. 2000;26:139-140.
25. Alves GJ, Palermo-Neto J. Neuroimunomodulação: sobre o diálogo entre os sistemas nervoso e imune. Rev Bras Psquiatr. 2007;29:363-369.
26. Kooker M. Mind, immunity and health - the science and clinical application of psycho-neuroimmunology. CME. 2008;26:18-20.
27. Óconnell-Edwards C, Jones DJ. CD4 count and physical symptoms among urban African American mothers with HIV: an examination of the role of optimism and depressive symptoms. J Clin Psychol Med Settings. 2008;15:322-330.
28. Ulla S, Remor EA. Psiconeuroimunologia e infecção por HIV: realidade ou ficção? Psicol Reflex Crit. 2002;15:113-119.